Respiratory Critical Care Nurse Training Program

NCT05941923 | Unknown

• 1 other identifier: Respiratory Nurse
• Study Type: interventional
• Target: 100
• Locations: 0 countries
• Sites: N/A

Brief Summary

The goal of this clinical trial study is to evaluate the clinical effectiveness of respiratory critical care nurses (RCCN) in improving outcomes for critically ill patients who require admission to the intensive care units (ICUs). The main question it aims to answer is: What is the effect of the respiratory critical care nurse in improving outcomes for critically ill patients? Participants will consist of critically ill patients who will be randomly allocated in a 1:1 ratio into two groups: the intervention group, who will receive specialized respiratory care from RCCN from the time they arrive in the emergency room until their discharge from the hospital, and the control group, who will receive only routine care.

Conditions

Morality; Treatment Compliance

Outcome Measures

Primary Outcomes (1)

• Mortality rate

  The primary outcome of this study will be to compare mortality rates between two study groups.

  through study completion, an average of 3 months

Secondary Outcomes (1)

• Treatment failures

  through study completion, an average of 3 months

Other Outcomes (10)

• Rate of endotracheal intubation

  through study completion, an average of 3 months

• Rate of non-invasive ventilation (NIV)

  through study completion, an average of 3 months

• Rate of ventilator-associated pneumonia (VAP)

  through study completion, an average of 3 months

Study Arms (2)

Intervention group

EXPERIMENTAL

The experimental group, who will receive specialized respiratory care from RCCN from the time they arrive in the emergency room until their discharge from the hospital

Other: respiratory critical care support

Control group

NO INTERVENTION

No intervention group, who will receive only routine care without any intervention.

Interventions

respiratory critical care support OTHER

Patients in the intervention group will be received respiratory critical care support

Intervention group

Eligibility Criteria

• Age: 18 Years - 95 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• They are at least 18 years old,
• Critically ill patients who need critical care,
• They have no history of heart disease, stroke, autoimmune disease, neuromuscular diseases, cancer, or cardio-respiratory arrest,
• They are willing to participate in the study.

You may not qualify if:

• Patients with pregnancy and breastfeeding women
• Patients at end-stage medical condition
• Patients with planned withdrawal of treatment

Sponsors & Collaborators

• Baqiyatallah Medical Sciences University: lead

MeSH Terms

Conditions

Patient Compliance

Condition Hierarchy (Ancestors)

Patient Acceptance of Health Care; Treatment Adherence and Compliance; Health Behavior; Behavior

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: TRIPLE
• Who Masked: PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
• Masking Details: Triple blinding : Patients, respiratory critical care nurses, and data analyzers will be blinded to the allocation
• Purpose: SUPPORTIVE CARE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Model Details: A randomized controlled clinical superiority trial with two-arm parallel group design

Study Record Dates

• First Submitted: June 22, 2023
• First Posted: July 12, 2023
• Study Start: November 1, 2023
• Primary Completion: November 1, 2024
• Study Completion: November 1, 2024
• Last Updated: July 12, 2023

Record last verified: 2023-07